Here you will find our latest press release.
For publications, please name the copyright as indicated in the pictures.

Current press release

Opposition against patent on ‘Alzheimer-apes’
Patented process causes severe animal suffering

Testbiotech has filed an opposition against a patent on ‘Alzheimer-animals’. The patent (EP3066203) covers rodents and non-human primates, including great apes. The animals are genetically engineered to develop symptoms of Alzheimer’s disease. The patented process causes severe suffering in the animals while, at the same time, any potential medical benefits are doubtful. The patent was granted by the European Patent Office (EPO) in 2020 to research institutions in France.

Further information:
The opposition (in German)
Read more

Press contact

For inquiries or interviews, please contact Christoph Then.

  • Email: info[at]testbiotech.org (without brackets)
  • Phone: 0151 54638040

Would you like to be included in our press mailing list?
Please send us an e-mail with subject "Press mailing" to the e-mail address above.

Further press releases

22 April 2021
First application for approval of CRISPR/Cas plants in the EU
Maize is resistant to herbicides and produces insecticides
25 January 2021
EU Commission approves eight applications for import of transgenic crops
Decision ignores recent studies and EU Parliament resolutions
21 January 2021
Risk assessment of GE plants in the EU: Taking a look at the ‘dark side of the moon’
New report provides evidence that EFSA systematically ignores specific risks
11 December 2020
Are GE plants with Bt toxins 20 times more toxic than previously known?
EFSA has for decades ignored crucial data from Monsanto
12 August 2020
‘New genetic engineering’ techniques associated with numerous risks
New scientific paper demonstrates the need for process oriented risk assessment

alle Pressemitteilungen